|
[1]
|
Atala, A. (2015) Re: TERT Promoter Mutations and Telomerase Reactivation in Urothelial Cancer. Journal of Urology, 194, 848-849. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Stasik, S., Salomo, K., Heberling, U., Froehner, M., Sommer, U., Baretton, G.B., et al. (2019) Evaluation of TERT Promoter Mutations in Urinary Cell-Free DNA and Sediment DNA for Detection of Bladder Cancer. Clinical Biochemistry, 64, 60-63. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Zvereva, M., Pisarev, E., Hosen, I., Kisil, O., Matskeplishvili, S., Kubareva, E., et al. (2020) Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer. International Journal of Molecular Sciences, 21, Article 6034. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Yang, C., Hung, W., Wang, S., Kang, W., Chen, W., Huang, Y., et al. (2008) Immunoexpression and Prognostic Role of HTERT and Cyclin D1 in Urothelial Carcinoma. APMIS, 116, 309-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
谭卿. 尿路上皮肿瘤TERT启动子突变的研究[D]: [博士学位论文]. 北京: 北京协和医学院, 2016.
|
|
[6]
|
刘扬, 邢雪莎, 王贺意, 罗阳, 王侠. 膀胱癌中TERT启动子突变分析及其复发的意义[J]. 现代泌尿外科杂志, 2017, 22(3): 176-180.
|
|
[7]
|
Descotes, F., Kara, N., Decaussin-Petrucci, M., Piaton, E., Geiguer, F., Rodriguez-Lafrasse, C., et al. (2017) Non-Invasive Prediction of Recurrence in Bladder Cancer by Detecting Somatic TERT Promoter Mutations in Urine. British Journal of Cancer, 117, 583-587. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Hosen, I., Rachakonda, P.S., Heidenreich, B., de Verdier, P.J., Ryk, C., Steineck, G., et al. (2015) Mutations in TERT Promoter and FGFR3 and Telomere Length in Bladder Cancer. International Journal of Cancer, 137, 1621-1629. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
El Azzouzi, M., El Ahanidi, H., Hassan, I., Tetou, M., Ameur, A., Bensaid, M., et al. (2024) Comprehensive Behavioural Assessment of TERT in Bladder Cancer. Urologic Oncology: Seminars and Original Investigations, 42, 451.e19-451.e29. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Roggisch, J., Ecke, T. and Koch, S. (2020) Molecular Identification of Telomerase Reverse Transcriptase (TERT) Promotor Mutations in Primary and Recurrent Tumors of Invasive and Noninvasive Urothelial Bladder Cancer. Urologic Oncology: Seminars and Original Investigations, 38, 77.e17-77.e25. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Pérez González, S., Heredia-Soto, V., Girón de Francisco, M., Pérez-Fernández, E., Casans-Francés, R., Mendiola Sabio, M., et al. (2024) Telomerase Reverse Transcriptase-Promoter Mutation in Young Patients with Bladder Tumors. Current Issues in Molecular Biology, 46, 2845-2855. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wang, K., Liu, T., Liu, C., Meng, Y., Yuan, X., Liu, L., et al. (2015) TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients with Urothelial Bladder Cancer. The Oncologist, 20, 263-269. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Dong, M., Cioffi, G., Wang, J., Waite, K.A., Ostrom, Q.T., Kruchko, C., et al. (2020) Sex Differences in Cancer Incidence and Survival: A Pan-Cancer Analysis. Cancer Epidemiology, Biomarkers & Prevention, 29, 1389-1397. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
韩仁强, 郑荣寿, 张思维, 等. 1989年-2008年中国肺癌发病性别、城乡差异及平均年龄趋势分析[J]. 中国肺癌杂志, 2013, 16(9): 445-451.
|
|
[15]
|
贺宇彤, 郑荣寿, 孙喜斌, 等. 中国恶性肿瘤性别发病差异分析[J]. 中国肿瘤, 2013, 22(3): 174-179.
|
|
[16]
|
李辉章, 郑荣寿, 杜灵彬, 等. 中国膀胱癌流行现状与趋势分析. 中华肿瘤杂志, 2021, 43(3): 293-298.
|
|
[17]
|
张志凌, 周芳坚. 膀胱癌的诊断和治疗进展[J]. 临床外科杂志, 2015, 23(2): 91-92.
|
|
[18]
|
Netto, G.J. (2011) Molecular Biomarkers in Urothelial Carcinoma of the Bladder: Are We There Yet? Nature Reviews Urology, 9, 41-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Cong, Y. (1999) The Human Telomerase Catalytic Subunit hTERT: Organization of the Gene and Characterization of the Promoter. Human Molecular Genetics, 8, 137-142. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Hafezi, F. and Perez Bercoff, D. (2020) The Solo Play of TERT Promoter Mutations. Cells, 9, Article 749. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Killela, P.J., Reitman, Z.J., Jiao, Y., et al. (2013) TERT Promoter Mutations Occur Frequently in Gliomas and a Subset of Tumors Derived from Cells with Low Rates of Self-Renewal. Proceedings of the National Academy of Sciences of the United States of America, 110, 6021-6026.
|
|
[22]
|
El Zarif, T., Machaalani, M., Nawfal, R., Nassar, A.H., Xie, W., Choueiri, T.K., et al. (2023) TERT Promoter Mutations Frequency across Race, Sex, and Cancer Type. The Oncologist, 29, 8-14. [Google Scholar] [CrossRef] [PubMed]
|